众生药业(002317.SZ)：获得盐酸氨溴索口服溶液《药品注册证书》

Core Viewpoint - Zhongsheng Pharmaceutical (002317.SZ) has received the drug registration certificate for Ambroxol Hydrochloride Oral Solution from the National Medical Products Administration, indicating a significant regulatory approval for a new product in its portfolio [1] Group 1: Product Information - Ambroxol Hydrochloride is a mucolytic agent that increases the secretion of serous glands in the respiratory mucosa and reduces the secretion of mucus glands, thereby lowering the viscosity of phlegm [1] - The product promotes the secretion of pulmonary surfactant and enhances bronchial ciliary movement, making it easier to expel phlegm [1] - The oral solution is indicated for the treatment of viscous phlegm and difficulty in expectoration caused by acute and chronic bronchitis, with clear diagnostic and therapeutic guidelines recommended [1]